Ascelia Pharma AB (publ) (STO:ACE)
Sweden
· Delayed Price · Currency is SEK 2.890
-0.010 (-0.34%)
At close: Mar 6, 2026
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 366.65 million as of March 6, 2026. Its market cap has increased by 13.37% in one year.
Market Cap
366.65M
Enterprise Value
317.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.89
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 366.65M, a decrease of -34.80%. That is a compound annual growth rate of -5.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 389.33M |
| Oncopeptides AB | 431.97M |
| Elicera Therapeutics AB | 308.69M |
| Lipum AB | 303.34M |
| Bio-Works Technologies AB | 278.39M |
| Mendus AB | 263.80M |
| FluoGuide | 557.51M |
| AlzeCure Pharma AB | 225.23M |